Afon Technology Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $5.08M

  • Investors
  • 4

Afon Technology General Information

Description

Developer of a non-invasive blood glucose monitoring device designed to transform diabetes management through real-time tracking without skin penetration. The company offers a wearable device with needle-free biosensing and clinically validated accuracy, enabling individuals with diabetes to monitor glucose levels comfortably and conveniently in daily life.

Contact Information

Formerly Known As
Invictus Wealth
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Unit 670 Castlegate Business Park
  • Monmouthshire
  • Caldicot NP26 5AD
  • Wales, United Kingdom
+44 01291
Primary Industry
Monitoring Equipment
Other Industries
Application Software
Corporate Office
  • Unit 670 Castlegate Business Park
  • Monmouthshire
  • Caldicot NP26 5AD
  • Wales, United Kingdom
+44 01291

Afon Technology Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Afon Technology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 05-Feb-2024 $5.08M Completed Product Development
3. Grant 01-Dec-2022 Completed Product Development
2. Later Stage VC (Series 3) 04-Aug-2022 $975K $6.3M Completed Product Development
1. Later Stage VC 30-Jun-2021 $5.33M $5.33M Completed Product Development
To view Afon Technology’s complete valuation and funding history, request access »

Afon Technology Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Ordinary
A Ordinary
E Ordinary
E Ordinary
A Ordinary
A Ordinary
A Ordinary 152,322 $0.001270 $3.18 $3.18 1x $3.18 3.54%
A Ordinary 1,049,460 $0.001270 $1.91 $1.91 1x $1.91 24.38%
To view Afon Technology’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Afon Technology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a non-invasive blood glucose monitoring device designed to transform diabetes management through real-time
Monitoring Equipment
Caldicot, United Kingdom
19 As of 2026

San Diego, CA
 

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Afon Technology Competitors (5)

One of Afon Technology’s 5 competitors is Biolinq, a Venture Capital-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Biolinq Venture Capital-Backed San Diego, CA
Nemaura Medical Corporation New York, NY
GWave Venture Capital-Backed Tel Aviv, Israel
DexCom Formerly VC-backed San Diego, CA
Abbott Corporation Abbot Park, IL
You’re viewing 5 of 5 competitors. Get the full list »

Afon Technology Patents

Afon Technology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024312680-A1 Determining a concentration of glucose in a subject's blood Pending 23-Jun-2023
AU-2024313070-A1 Determining a concentration of glucose in a subject's blood Pending 23-Jun-2023
EP-4731071-A1 Determining a concentration of glucose in a subject's blood Pending 23-Jun-2023
EP-4731072-A1 Determining a concentration of glucose in a subject's blood Pending 23-Jun-2023
GB-202309524-D0 Determining a concentration of glucose in a subject's blood Pending 23-Jun-2023 A61B5/14532
To view Afon Technology’s complete patent history, request access »

Afon Technology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Afon Technology Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Inspira Financial Trust PE-Backed Company Minority
European Innovation Council Accelerator/Incubator Minority
McKenny-McFarlane Capital PE/Buyout Minority
Norcliffe Capital Venture Capital Minority
To view Afon Technology’s complete investors history, request access »

Afon Technology FAQs

  • When was Afon Technology founded?

    Afon Technology was founded in 2015.

  • Where is Afon Technology headquartered?

    Afon Technology is headquartered in Caldicot, United Kingdom.

  • What is the size of Afon Technology?

    Afon Technology has 19 total employees.

  • What industry is Afon Technology in?

    Afon Technology’s primary industry is Monitoring Equipment.

  • Is Afon Technology a private or public company?

    Afon Technology is a Private company.

  • What is the current valuation of Afon Technology?

    The current valuation of Afon Technology is .

  • What is Afon Technology’s current revenue?

    The current revenue for Afon Technology is .

  • How much funding has Afon Technology raised over time?

    Afon Technology has raised $11.4M.

  • Who are Afon Technology’s investors?

    Inspira Financial Trust, European Innovation Council, McKenny-McFarlane Capital, and Norcliffe Capital have invested in Afon Technology.

  • Who are Afon Technology’s competitors?

    Biolinq, Nemaura Medical, GWave, DexCom, and Abbott are competitors of Afon Technology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process